DOS_patos
Unverified Legion of Trill member
When compared to all other populations combined, the African genome is the most genetically diverse in the world. This diversity holds significant potential for the healthcare of Africans and the entire world.
Committed to Global Health
We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.
Through our research collaborations and commercial partnerships, we will enable the study of African genetics to learn the underlying genetic drivers of disease affecting everyone globally.
Additionally, we strive to understand the genetic impact on disease penetrance and risk in Africans with a goal of developing better diagnostic and risk assessment tests to inform a more targeted approach to healthcare.
Our Focus Areas
54gene is currently focused on genomic studies in the following areas:
Non-Communicable Diseases
In 2015, NCDs accounted for 40 million of the 56 million global deaths. Since then, the burden of disease has been on the rise affecting people, families and communities while the genetic basis of highly prevalent NCDs across Africa remains relatively unknown. In this focus area, we are studying the following diseases: Cancer, Endocrine disorders, Neuro-degenerative diseases, Cardiovascular disease, Sickle Cell Disease
Infectious Diseases
Infectious diseases are disorders caused by bacteria, viruses, fungi or parasites. These diseases account for a high percentage of mortality across African populations. Understanding the genetic basis of these diseases will provide new insights that could enhance treatment. In this focus area, we intend to study infectious diseases that are particularly prevalent across Africa.
The 54gene Biobank™
The 54gene Biobank™ is our state-of-the-art biorepository. It is a facility which stores biological samples in the right conditions so the sample retains its integrity for when it is needed for research.
Our biobank is currently located in Africa's most populous country, Nigeria, with the goal of serving as a resource for the global health community to ensure Africans benefit from cutting edge medical innovation.
The purpose our biobank serves is to provide access to aggregated data, de-identified samples and bio-specimen mainly for secondary use by researchers. We are equally open to supporting both academic and development research.
Our dedicated clinical and research teams are committed to using our vast genetic database to support development of therapeutics including drugs and vaccines for non-communicable and communicable diseases in various ways.
Committed to Global Health
We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.
Through our research collaborations and commercial partnerships, we will enable the study of African genetics to learn the underlying genetic drivers of disease affecting everyone globally.
Additionally, we strive to understand the genetic impact on disease penetrance and risk in Africans with a goal of developing better diagnostic and risk assessment tests to inform a more targeted approach to healthcare.
Our Focus Areas
54gene is currently focused on genomic studies in the following areas:
Non-Communicable Diseases
In 2015, NCDs accounted for 40 million of the 56 million global deaths. Since then, the burden of disease has been on the rise affecting people, families and communities while the genetic basis of highly prevalent NCDs across Africa remains relatively unknown. In this focus area, we are studying the following diseases: Cancer, Endocrine disorders, Neuro-degenerative diseases, Cardiovascular disease, Sickle Cell Disease
Infectious Diseases
Infectious diseases are disorders caused by bacteria, viruses, fungi or parasites. These diseases account for a high percentage of mortality across African populations. Understanding the genetic basis of these diseases will provide new insights that could enhance treatment. In this focus area, we intend to study infectious diseases that are particularly prevalent across Africa.
The 54gene Biobank™
The 54gene Biobank™ is our state-of-the-art biorepository. It is a facility which stores biological samples in the right conditions so the sample retains its integrity for when it is needed for research.
Our biobank is currently located in Africa's most populous country, Nigeria, with the goal of serving as a resource for the global health community to ensure Africans benefit from cutting edge medical innovation.
The purpose our biobank serves is to provide access to aggregated data, de-identified samples and bio-specimen mainly for secondary use by researchers. We are equally open to supporting both academic and development research.
Our dedicated clinical and research teams are committed to using our vast genetic database to support development of therapeutics including drugs and vaccines for non-communicable and communicable diseases in various ways.
